SmartTRAK just returned from the May 3-5, 2017 EWMA European Wound Management Association Meeting held in Amsterdam.  Great conference! Our very own Susan Paquette,  Vice President and General Manager, Wound for SmartTRAK spoke at the Wound Innovation Symposium on the "State of the Wound Care Market."  We will have an excerpt of the speech up on the blog soon, with the full post of the speech including slides, posted on SmartTRAK.net for our subscribers.

In the meantime, Susan and team have shared a few photos from the conference!

SmartTRAK's Tim Jeavons, Susan Paquette and Lennart Stadler (left to right) attending the 27th conference of European Wound Management Association.  SmartTRAK has local experts in the EU to keep on top of events and news from Europe.  

It’s been less than a year since Nuvectra Medical spun-off from Greatbatch Inc. (now Integer), and in that time Nuvectra has built a sales organization and laid the organizational foundation to become a, multi-indication neurostimulation company.

FDA allowing use of historical controls may overcome a significant barrier and expedite pt enrollment in cartilage repair IDE trials notes Jack Farr, MD, at 2016 ICRS.

Injectable treatments will never turn a bad joint into a good one but may relieve pain for an undetermined period of time, concludes Elizaveta Kon, MD, in a conversation with BioMedGPS at the 2016 ICRS. Dr. Kon has performed extensive research comparing injectable technologies (e.g., PRP, HA, BMAC) and believes their primary role is in treating pain in pts who wish to avoid surgery. 

From government policy to market shifts, value-based care initiatives are driving change, and some see the challenges as opportunity

Ironically, there is a greater need for a cartilage replacement technology in the ankle than in the knee, reports Richard Ferkel, MD, in a video interview with BioMedGPS at 2016 ICRS. The frequency of OCD lesions of the talar dome is about 5X greater than in the knee based on Ferkel's experience, who emphasizes the need for a single stage cartilage repair technology.

SmartTRAK is pleased to announce that its Advanced Wound Care Market Intelligence data now includes both Europe and Asia. 

AAOS Shifts Focus From Efficacy to Cost

The American Association of Orthopedic Surgeons (AAOS) has shifted their focus from efficacy to costs in their offensive against intra-articular hyaluronic acid therapy

SmartTRAK is inviting its subscribers and colleagues to a special event, the Wound Care Innovation Symposium, being held during EWMA (European Wound Management Association) in Amsterdam on May 4, 2017 from 3pm to 7pm. Susan Paquette, Vice President and General Manager of Wound, SmartTRAK-BioMedGPS, will be presenting the "State of the Wound Care Market" during the event. The full agenda can be found at Symposium Agenda.